Atlas Trials

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

Clinical trial NCT05237960 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05237960
Sponsor
University of Arizona
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ErythroplakiaOral Leukoplakia
Start date
2023-01-12
Primary completion
2025-11-07
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.